RSID | rs2531743 |
HGVS | NC_000003.12:g.45796808G>A |
Chromosome | 3 |
Start position | 45796808 |
Stop position | 45796808 |
Associated gene(s) | SLC6A20, LOC107986082,LZTFL1, SACML1, CCR9, FYCO1, XCR1, CCR3, CCR1 |
Mutation type | Tagged SNP |
Reference | G |
Alternative | A,C,T |
Associated allele | A |
Associated African Allele Frequency | 0.4753 |
Consequence | Upstream transcript variant |
Other population frequencies link | ALFA rs2531743 |
Name | Paper | Description of Comparison | Gene | RSID | Association | Disease Status | MAF | Statistical Odds Ratio | Statistical P-value |
---|---|---|---|---|---|---|---|---|---|
Horowitz_rs2531743 | Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease | Meta analysis, External data | SLC6A20, LOC107986082,LZTFL1, SACML1, CCR9, FYCO1, XCR1, CCR3, CCR1 | rs2531743 | Positive | Susceptibility | 0.42 | 1.06 | 0.0009 |
Horowitz_2_rs2531743 | Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease | COVID-19 positive vs COVID-19 negative | SLC6A20 | rs2531743 | positive | Susceptibility | 42.0 | 0.94 | 0.000000000003 |